Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening
Launched by CNGE CONSEIL · Oct 6, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how training general practitioners (doctors) to use a patient-centered approach affects shared decision-making during colorectal cancer screening. The goal is to see if this training helps doctors better involve patients in decisions about their screening options, compared to doctors who haven't received this training.
To participate in the study, you need to be between the ages of 50 and 74 and eligible for organized colorectal cancer screening. This means you should have a regular doctor involved in your care and be willing to follow the study's requirements. However, you cannot join if you have had a screening in the last two years, have certain medical conditions like a personal history of colorectal cancer, or if you have difficulty understanding the study materials. If you join, you can expect to work closely with your doctor and potentially help improve the way doctors and patients communicate about important health decisions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient aged 50 to 74:
- • Eligible for organized CRC screening,
- • Having declared as attending clinician a general practitioner investigator of the study
- • ✓ Consulting their attending clinician for the duration of the study,
- • AND able and willing to comply with all trial requirements
- Non inclusion Criteria:
- • - ✓ Screened for CRC less than 2 years ago
- * Not eligible for organized CRC screening:
- * History of adenomas or CRC:
- • - Family (1st degree)
- * Personal history of IBD:
- • Crohn's disease
- • Ulcerative colitis)
- * Hereditary predispositions:
- • Familial adenomatous polyposis
- • Hereditary non-polyposis colorectal cancer (Lynch syndrome)
- • Patient with symptoms requiring colonoscopy
- • Having a level of literacy that does not allow the completion of the self-questionnaire.
- • Having an inability to give express consent.
- • Being under guardianship, curatorship or having cognitive disorders
About Cnge Conseil
CNGE Conseil is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through strategic research and development. With a strong emphasis on collaboration and scientific excellence, CNGE Conseil specializes in designing and managing clinical trials across various therapeutic areas. Their team of experienced professionals is committed to ensuring compliance with regulatory standards while prioritizing patient safety and data integrity. By leveraging cutting-edge methodologies and a robust network of clinical sites, CNGE Conseil aims to expedite the development of new treatments, ultimately improving patient outcomes and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Soisy Sous Montmorency, , France
Patients applied
Trial Officials
Isabelle AUGER-AUBIN, Pr
Study Chair
cabinet de groupe pluriprofessionnel 40 rue Carnot 95230 Soisy-Sous-Montmorency
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported